Successful recovery from COVID-19 in three kidney transplant recipients who received convalescent plasma therapy.
COVID-19
convalescent plasma
immunosuppression
kidney transplant recipient
viral pneumonia
Journal
Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Titre abrégé: Transpl Infect Dis
Pays: Denmark
ID NLM: 100883688
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
16
06
2020
revised:
10
08
2020
accepted:
11
08
2020
pubmed:
21
8
2020
medline:
10
3
2021
entrez:
21
8
2020
Statut:
ppublish
Résumé
Novel coronavirus disease 2019 (COVID-19) is a highly infectious, rapidly spreading viral disease that typically presents with greater severity in patients with underlying medical conditions or those who are immunosuppressed. We present a novel case series of three kidney transplant recipients with COVID-19 who recovered after receiving COVID-19 convalescent plasma (CCP) therapy. Physicians should be aware of this potentially useful treatment option. Larger clinical registries and randomized clinical trials should be conducted to further explore the clinical and allograft outcomes associated with CCP use in this population.
Identifiants
pubmed: 32815238
doi: 10.1111/tid.13451
pmc: PMC7460867
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13451Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Clin Infect Dis. 2011 Feb 15;52(4):447-56
pubmed: 21248066
Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6
pubmed: 15616839
Biosci Trends. 2020 Mar 16;14(1):69-71
pubmed: 31996494
JAMA. 2020 Apr 28;323(16):1582-1589
pubmed: 32219428
N Engl J Med. 2007 Sep 13;357(11):1162-3
pubmed: 17855683
Transfusion. 2019 Jul;59(7):2465-2476
pubmed: 30993745
Am J Transplant. 2019 Jun;19(6):1720-1729
pubmed: 30582278
Emerg Infect Dis. 2016 Sep;22(9):1554-61
pubmed: 27532807
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Transfusion. 2015 Aug;55(8):1825-8
pubmed: 26264120
Transpl Infect Dis. 2021 Feb;23(1):e13451
pubmed: 32815238
Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767
pubmed: 29161116
Emerg Infect Dis. 2020 Jun;26(6):1339-1441
pubmed: 32168463
J Microbiol Immunol Infect. 2020 Jun;53(3):365-367
pubmed: 32035811
JAMA. 2020 Apr 21;323(15):1499-1500
pubmed: 32159735
Nat Rev Neurol. 2015 Feb;11(2):80-9
pubmed: 25561275
Transfus Clin Biol. 2016 Feb;23(1):39-44
pubmed: 26775794
J Immunol. 2001 Oct 1;167(7):3910-8
pubmed: 11564809
Transfusion. 2012 May;52 Suppl 1:65S-79S
pubmed: 22578374
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496
pubmed: 32253318
Antivir Ther. 2018;23(7):617-622
pubmed: 29923831
Lancet. 2020 Feb 15;395(10223):473-475
pubmed: 32043983